Literature DB >> 12750477

Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor.

Saghi Ghaffari1, Zainab Jagani, Claire Kitidis, Harvey F Lodish, Roya Khosravi-Far.   

Abstract

Cytokine-provided survival signals are known to suppress apoptosis through inhibition of mitochondrial pathways that involve Bcl-2 family members. Here we show that in hematopoietic cells, cytokines also regulate death receptor-mediated pathways. We demonstrate that hematopoietic cytokines such as IL-3 and erythropoietin in normal cells, as well as BCR-ABL oncoprotein in transformed cells, inhibit transcription of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). Using small interfering RNAs, we show that the inhibition of TRAIL function is sufficient to partially rescue cytokine-deprived cells from apoptosis. Finally, we demonstrate that cytokine and BCR-ABL suppression of TRAIL transcription is mediated through phosphorylation and inhibition of the forkhead FOXO3a transcription factor. BCR-ABL-induced inhibition of TRAIL transcription in hematopoietic cells may provide a novel mechanism for tumorigenicity in chronic myeloid leukemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12750477      PMCID: PMC164479          DOI: 10.1073/pnas.0731871100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Apoptosis signaling.

Authors:  A Strasser; L O'Connor; V M Dixit
Journal:  Annu Rev Biochem       Date:  2000       Impact factor: 23.643

2.  Isolation and molecular characterization of the 5'-upstream region of the human TRAIL gene.

Authors:  Q Wang; Y Ji; X Wang; B M Evers
Journal:  Biochem Biophys Res Commun       Date:  2000-09-24       Impact factor: 3.575

3.  Bcl-2 expression restores the leukemogenic potential of a BCR/ABL mutant defective in transformation.

Authors:  M Cirinnà; R Trotta; P Salomoni; P Kossev; M Wasik; D Perrotti; B Calabretta
Journal:  Blood       Date:  2000-12-01       Impact factor: 22.113

Review 4.  Growth factor independence and BCR/ABL transformation: promise and pitfalls of murine model systems and assays.

Authors:  S Ghaffari; G Q Daley; H F Lodish
Journal:  Leukemia       Date:  1999-08       Impact factor: 11.528

5.  Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a).

Authors:  A Brunet; J Park; H Tran; L S Hu; B A Hemmings; M E Greenberg
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

6.  The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf.

Authors:  M S Neshat; A B Raitano; H G Wang; J C Reed; C L Sawyers
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

7.  Apo2 ligand/TNF-related apoptosis-inducing ligand and death receptor 5 mediate the apoptotic signaling induced by ionizing radiation in leukemic cells.

Authors:  B Gong; A Almasan
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

8.  Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1.

Authors:  P F Dijkers; R H Medema; J W Lammers; L Koenderman; P J Coffer
Journal:  Curr Biol       Date:  2000-10-05       Impact factor: 10.834

9.  BCR-ABL and v-SRC tyrosine kinase oncoproteins support normal erythroid development in erythropoietin receptor-deficient progenitor cells.

Authors:  S Ghaffari; H Wu; M Gerlach; Y Han; H F Lodish; G Q Daley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

10.  Bcr/Abl activates transcription of the Bcl-X gene through STAT5.

Authors:  F Gesbert; J D Griffin
Journal:  Blood       Date:  2000-09-15       Impact factor: 22.113

View more
  52 in total

Review 1.  The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation.

Authors:  Lars P Van Der Heide; Marco F M Hoekman; Marten P Smidt
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

2.  Foxo3 is required for the regulation of oxidative stress in erythropoiesis.

Authors:  Dragan Marinkovic; Xin Zhang; Safak Yalcin; Julia P Luciano; Carlo Brugnara; Tara Huber; Saghi Ghaffari
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

3.  FoxO3a and BCR-ABL regulate cyclin D2 transcription through a STAT5/BCL6-dependent mechanism.

Authors:  Silvia Fernández de Mattos; Abdelkader Essafi; Inês Soeiro; Alexandra M Pietersen; Kim U Birkenkamp; Corinne S Edwards; Anthony Martino; Brad H Nelson; Julia M Francis; Marius C Jones; Jan J Brosens; Paul J Coffer; Eric W-F Lam
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

4.  Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic marker.

Authors:  Rajan Dewar; Sing-Tsung Chen; Heather Yeckes-Rodin; Kenneth Miller; Roya Khosravi-Far
Journal:  Cancer Biol Ther       Date:  2011-03-15       Impact factor: 4.742

5.  Apoptosis in gingival overgrowth tissues.

Authors:  A Kantarci; P Augustin; E Firatli; M C Sheff; H Hasturk; D T Graves; P C Trackman
Journal:  J Dent Res       Date:  2007-09       Impact factor: 6.116

6.  Erythropoietin stimulates phosphorylation and activation of GATA-1 via the PI3-kinase/AKT signaling pathway.

Authors:  Wei Zhao; Claire Kitidis; Mark D Fleming; Harvey F Lodish; Saghi Ghaffari
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

Review 7.  Transcriptional regulation of tumour necrosis factor-related apoptosis-inducing ligand.

Authors:  Nor Saadah M Azahri; Mary M Kavurma
Journal:  Cell Mol Life Sci       Date:  2013-01-18       Impact factor: 9.261

Review 8.  FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.

Authors:  Zainab Jagani; Amrik Singh; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2007-10-16

9.  EPO receptor circuits for primary erythroblast survival.

Authors:  Pradeep Sathyanarayana; Arvind Dev; Jing Fang; Estelle Houde; Olga Bogacheva; Oleg Bogachev; Madhu Menon; Sarah Browne; Anamika Pradeep; Christine Emerson; Don M Wojchowski
Journal:  Blood       Date:  2008-03-18       Impact factor: 22.113

10.  Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT.

Authors:  Amrik Singh; Min Ye; Octavian Bucur; Shudong Zhu; Maria Tanya Santos; Isaac Rabinovitz; Wenyi Wei; Daming Gao; William C Hahn; Roya Khosravi-Far
Journal:  Mol Biol Cell       Date:  2010-01-28       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.